The company, a spinout from the Diagnostic Development Unit of Cambridge University, has the Wellcome Trust and University of Cambridge as shareholders. It occupies five suites in the Science Village building, joining companies such as Isogenica, Isomerase and Cellulac within the purpose built development of individual, self-contained R&D suites.
DRW is committed to tackling some of the world's most serious infectious diseases by making breakthrough point-of care diagnostics, developed in the Diagnostic Development Unit of Cambridge University, widely available in places of very limited resource. The company currently offers rapid and reliable tests for Chlamydia, Hepatitis and HIV and is specifically focused on providing rapid Early Infant Diagnosis (EID) as well as Viral Load (VL) measurement for those living with HIV, thereby enabling test-and-treat facilities to be established in even the most challenging and resource-limited environments.
DRW’s mission is to make these cutting-edge technologies and diagnostic assays available in resource poor countries primarily through patient sample testing at the point of care or near the patient. Avoiding both the unreliability of previous simple point-of-care technologies and the prohibitive costs and logistical difficulties associated with central laboratory testing, DRW's technologies provide a fast, accurate and cost-effective method for testing and diagnosis when and where it is most needed.
Craig Wisniewski, Director of Engineering and Manufacturing commented of the move to the Park: “In researching locations we visited Cambridge Science Park, Granta Park and Capital Park at Fulbourn but Chesterford offered us the most suitable, ‘plug and play’ accommodation available in the area. The tranquil environment and facilities available within The Nucleus are great additions too – I have heard nothing but praise for the Nucleus restaurant.”
The Science Village at Chesterford Research Park is an ideal HQ for both established and start-up companies which need flexible, high quality and prestigious self-contained accommodation. The innovative, energy efficient building offers individual R&D suites ranging from 1,515 sq ft to 1,993 sq ft, plus excellent flexibility by combining spaces for larger occupation. The fully fitted accommodation - served by high-speed data connectivity and Cat 6 cabling - is also supported by a back up generator. Each suite has demountable benching; two sinks and two fume hoods (with space for a third if required), housed within their own dedicated room.
*******
For further information regarding occupancy options please contact the joint agents for Chesterford Research Park – William Clarke at Savills (01223) 347294 or Michael Jones at Dodson Jones (01223) 358114.
______________________________________